SIGA Technologies Inc. (SIGA) Posts Positive Q2 Results; Attributes Smallpox Treatment and Strategic Relationships to Success
SIGA Technologies Inc. (Nasdaq: SIGA) applies viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases. The company focuses on utilizing these products for biological warfare defense. The company today announced its second-quarter results for 2008, posting positive results due to its continued research and manufacturing efforts. SIGA recognized grants and contracts totaling $1.7 million for the period ended June 30, 2008, up 19 percent compared to the second quarter of 2007. Six-month revenues at $3.7 million represent a 12 percent increase from the $3.3…